STAT asked a fourth-year medical student about what affirmative action has meant...
AstraZeneca said on Monday that a new lung cancer treatment outperformed standar...
If pharma doesn’t step up now, this moment will pass the industry by.
Attendees at the Psychedelic Science conference heard an array of explanations f...
"A very intricate coaching app where you tell them every hour what they've done ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech eve...
Some medical school and educational leaders are hopeful that a path exists to di...
The approval of Sarepta Therapeutics’ gene therapy, Elevidys, is an ecstatic mom...
Chime Biologics, Leads Biolabs and BeiGene have entered a strategic partnership ...
The NDA includes pivotal data from Phase III trials and a long-term extension, w...
In late June 2023, Celltrion (South Korea) withdrew its key anti-cancer biosimil...
The bioscience company has received $10m Series A financing from asset manager M...
Baudax Bio has acquired all outstanding equity interests of biotechnology firm T...
2023 started with a buzz around ChatGPT, and more generally around the immense p...
The Humira biosimilar from Boehringer Ingelheim launches amidst a loss of exclus...
Pipeline developments within the obesity space have recently garnered interest f...
